Latest Cepheid (CPHD) Headlines 2014 Analysis o
Post# of 27
Posted On: 03/13/2014 7:01:42 AM
Latest Cepheid (CPHD) Headlines
2014 Analysis of the UK Hepatitis Diagnostics Market: Hospitals, Blood Banks, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
M2 - Mon Mar 10, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rjsvbf/2014_analysis_of) has announced the addition of the "2014 Analysis of the UK Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures" report to their offering. The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial/Private Labs - Blood Banks - Public Health Labs In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics/Grifols - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/rj...nalysis_of About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
43.9% Return Seen to Date on SmarTrend Cepheid Call (CPHD)
Comtex SmarTrend(R) - Fri Mar 07, 11:02AM CST
SmarTrend identified an Uptrend for Cepheid (NASDAQ:CPHD) on September 5th, 2013 at $37.73. In approximately 6 months, Cepheid has returned 43.95% as of today's recent price of $54.31.
Uptrend Call Working As Cepheid Stock Rises 45.6% (CPHD)
Comtex SmarTrend(R) - Fri Feb 28, 9:38AM CST
SmarTrend identified an Uptrend for Cepheid (NASDAQ:CPHD) on September 5th, 2013 at $37.73. In approximately 6 months, Cepheid has returned 45.61% as of today's recent price of $54.93.
Concise Analysis of the International Cancer Test Market
M2 - Thu Feb 27, 4:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/lbhbjn/cancer_test) has announced the addition of the "Concise Analysis of the International Cancer Test Market" report to their offering. Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year around the world than AIDS, Tuberculosis and Malaria combined. Cancer testing has tremendous growth opportunities for the next five years. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Accordingly, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The global cancer test market is expected to be more than US$ 14 Billion by 2018. This study provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters. Key Topics Covered: Table of Contents 1. Executive Summary 2. Global - Cancer Testing Market and New Cases 3. Global - Cancer Testing Market Share 4. Global - Segment Wise Cancer Testing Market 5. Global - Organ Specific Cancer Testing Market 6. Cancer Diagnostics- Companies Novel Test Platforms & Pipeline Analysis (20 Companies Analysis) Companies Mentioned: - Abbott - BD Diagnostics - Beckman Coulter - BioCurex - Cepheid - CytoCore - DiagnoCure - Gen-Probe - Genomic Health - Myriad Genetics - Panacea Pharmaceuticals - QIAGEN Marseille (Earlier Ipsogen) - Qiagen - Radient Pharmaceuticals - Roche - Siemens Heathcare Diagnostics - TrovageneInc. - Ventana Medical Systems - Vermillion - bioMerieux For more information visit http://www.researchandmarkets.com/research/lb...ancer_test
US Automated Microbiology Market 2014
M2 - Wed Feb 26, 9:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/p8czll/us_automated) has announced the addition of the "US Automated Microbiology Market 2014: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. United States Automated Microbiology Market 2014 is a new analysis of major business opportunities emerging in the US automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Specimen Types - Urine - Sterile Fluids: Blood, Serum, CSF - Throat Swabs, Respiratory Secretions - Genital Secretions - Stool - Abscess/Wound - Sputum - Saliva Applications - Microbial Identification - Antibiotic Susceptibility - Urine Screening - Blood Cultures Review of Major Automated Systems - Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers. The report profiles analyzers manufactured by: Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh. Technology Review - Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market. - Global listings of companies developing or marketing microbiology products by individual test. For more information visit http://www.researchandmarkets.com/research/p8..._automated About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Enteric Disease Testing Market 2014-2018: New Emerging Viruses and Bacteria Playing an Important Role in Diagnostics Industry
M2 - Wed Feb 26, 6:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/lrghlr/global_enteric) has announced the addition of the "Global Enteric Disease Testing Market 2014-2018" report to their offering. The analysts forecast the Global Enteric Disease Testing market to grow at a CAGR of 2.83 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of enteric diseases. The Global Enteric Disease Testing market has also been witnessing the emergence of new pathogens causing infections. However, the stringent regulatory approval could pose a challenge to the growth of this market. Key vendors dominating this space are Alere Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Cepheid Inc. and DiaSorin S.p.A. Other vendors mentioned in the report are Affymetrix Inc., Beckton, Dickenson and Co., Biomerica Inc., Coris BioConcept, Danaher Corp., Meridian Bioscience Inc., Quest Diagnostics Inc., R-Biopharm AG, and Trinity Biotech PLC. Commenting on the report, an analyst from the team said: Vendors are introducing new diagnostic tests for new found pathogens that are responsible for some other types of infectious diseases. These new pathogens include West Nile virus, respiratory syncytial virus, genital mycoplasma, C. difficile, norovirus, and rotavirus. C. difficile and rotavirus tests have seen the maximum level of acceptance in the market. Thus, the improvement in detection technology aiding in the identification of new pathogens is driving the need for enteric disease testing products. According to the report, one of the major drivers in the market is the increasing incidence of enteric diseases among the population, creating a need for testing methods that effectively diagnose diseases. For more information visit http://www.researchandmarkets.com/research/lr...al_enteric About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
A Whole New Opportunity For Hologic Inc?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Mon Feb 24, 5:30PM CST
Women's health specialist Hologic has had a rough go of it. At a time when most companies in the medical equipment or diagnostics markets can look back on a great two-year run in their share prices, Hologic's shares have chopped around and gone...
Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Mon Feb 24, 5:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/x9dvt9/molecular) has announced the addition of the "Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Molecular diagnostics primarily refers to a class of diagnostic test that analyzes nucleic acids or proteins at a molecular level. This class of diagnostics is identified as rapidly evolving and fastest growing segment of in-vitro diagnostics industry. Moreover, it is also considered as the most attractive and well established market for clinical applications. Traditionally, usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. But reduction in cost per sample analysis and labor cost, improvements in automation and introduction of advanced technologies has expanded the usage of molecular diagnostics in wide range of applications. The market for molecular diagnostics has expanded since 1990's with the introduction of PCR test for HIV and Chlamydia Trachomatis/Neisseria Gonorrhoeae (CT/NG). It is estimated that in the U.S. over 600 laboratories and 200 independent laboratories perform molecular diagnostics test to simplify and accelerate the testing process. Nowadays, molecular diagnostics tests are widely being adopted for testing infectious diseases (HIV, HCV, HPV HAI and others), genetic diseases, cancer testing and HLA testing. Similarly, molecular diagnostic kits are being used for blood donor screening and pharmacogenetics testing. Growth of this market in various segments is fuelled by the rise in incidence of chronic infections, growing geriatric population, increasing investments in R&D and increasing demand for personalized medicines. Currently, molecular diagnostics revenue is dominated by infectious diseases, capturing more 50% of the market share. Furthermore, growth of this segment will be triggered by rising incidences of hospital acquired infections (HAI) and thus HAI testing market is expected to witness a fastest growth rate in near future. This market is poised to grow at a CAGR of 15.1% from 2013-2019. HAI is being identified as a major cause of death and morbidity among hospitalized patients. It is estimated that each year approximately 14,000 Americans are diagnosed with C.difficile hospital acquired infection each year. Therefore, hospitals continue to adopt HAI testing as more virulent strains of these infections continue to surge. Similarly, rising cancer incidence is expected to drive the market for oncology testing and HPV testing during the analysis period. Next generation sequencing is growing rapidly and is estimated to emerge as the fastest growing segment. The technique is gaining importance owing to its rapid turnaround time, sensitivity and reduction in cost of sequencing. PCR market that accounted for a maximum share of the total molecular diagnostics market in 2012 is estimated to decline due to evolution of high throughput sequencing techniques. Key Topics Covered - Preface - Executive Summary - Market Overview - Molecular Diagnostics Market, by Technology - Global Molecular Diagnostics Market, by Applications - Global Molecular Diagnostics Market, by Geography - Global Molecular Diagnostics Market Share Analysis - Recommendations - Company Profiles Companies Mentioned - Abbott Laboratories - Becton Dickinson & Company - Bio-Rad - bioMerieux - Cepheid - Danaher Corporation (Beckman Coulter) - F. Hoffmann-La Roche - Hologic (Gen-Probe) - Myriad Genetics - Novartis International - Qiagen - Quest Diagnostics - Siemens - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/x9dvt9/molecular About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Updated Research Report on Cepheid - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 2:00PM CST
Recently, we issued an updated research report on Cepheid.
Respiratory Diseases in the US 2014: Market Outlook and Emerging Opportunities
M2 - Fri Feb 21, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/3tw5kb/respiratory) has announced the addition of the "Respiratory Diseases in the US 2014: Market Outlook and Emerging Opportunities" report to their offering. This new 283-page report presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for microbiology testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.. Methodology - The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. - In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the author's proprietary data files was conducted. Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - BioRad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio - GenProbe - Hologic - ID Biomedical Innogenetics/Solvay - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - OrthoClinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac - Wako For more information visit http://www.researchandmarkets.com/research/3t...espiratory About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Cepheid Shares Up 40.5% Since SmarTrend's Buy Recommendation (CPHD)
Comtex SmarTrend(R) - Fri Feb 21, 9:10AM CST
SmarTrend identified an Uptrend for Cepheid (NASDAQ:CPHD) on September 5th, 2013 at $37.73. In approximately 6 months, Cepheid has returned 40.49% as of today's recent price of $53.00.
Becton, Dickinson & Co Poised To Be A Large-Cap Growth Leader
Stephen D., Simpson,, The Motley Fool - Motley Fool - Wed Feb 19, 1:38PM CST
When the worst thing you can say about a company is that its stock doesn't look very cheap, that's not a bad situation. It is challenging for me to see substantial undervaluation in Becton Dickison these days, even given the company's excellent...
TDS and U.S. Cellular to release fourth quarter operating results and host conference call on Feb. 26, 2014
PR Newswire - Wed Feb 19, 9:44AM CST
Telephone and Data Systems, Inc. (NYSE: TDS) and United States Cellular Corporation (NYSE: USM) will be webcasting their fourth quarter operating results conference call on Feb. 26, 2014, at 10:30 a.m. EST (9:30 a.m. CST).
2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Blood Culture, Urine Screening and Immunodiagnostics
M2 - Tue Feb 18, 8:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/48jvmv/2014_automated) has announced the addition of the "2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. '2014 Automated Microbiology Market--A Global Strategic Outlook' is a new seven-country strategic analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies. Worldwide Market Overview - Estimated universe of laboratories performing microbiology testing by country. - Specimen, test volume and sales forecasts by country. Market Segmentation Analysis - Sales and market shares for major suppliers by individual test and country. - Volume and sales forecasts for over 100 infectious disease assays by individual test and country. - Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). - Review of the market dynamics, trends, structure, size, growth and major suppliers by country Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Exact Sciences - Fujirebio/Innogenetics - Hologic/Gen-Probe - Illumina - ID Biomedical/GSK - Kreatech - Li-Cor Biosciences - Life Technology - Lonza - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Novartis Diagnostics/Grifols - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Sierra Molecular - Shimadzu - Takara Bio - Tecan - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/48..._automated About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
European Automated Microbiology Market 2014: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Urine Screening, Immunodiagnostics
M2 - Tue Feb 18, 8:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/g2qklv/european) has announced the addition of the "European Automated Microbiology Market 2014: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. 'European Automated Microbiology Market 2014' is a new five-country strategic analysis of major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. This comprehensive five-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding European microbiology market, in evaluating emerging opportunities and developing effective business strategies. Geographic Coverage France, Germany, Italy, Spain and the UK Market Segmentation Analysis - Sales and market shares for major suppliers by individual test and country. - Volume and sales forecasts for over 100 infectious disease assays by individual test and country. - Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). - Review of the market dynamics, trends, structure, size, growth and major suppliers by country. Companies Mentioned: - Abbott - Alifax - Anagen - BD - Beckman Coulter/Danaher - Biochem - Biolog - bioMerieux - Bio-Rad - Biotrol - Cepheid - Curetis - GenMark - Hologic/Gen-Probe - HTG - Iris - J&J - Labsystems - Life Technologies - MiDI - Olympus - Qiagen - Roche - Siemens - Sy-Lab - Sysmex - Tecan - Thermo Fisher - Tosoh For more information visit http://www.researchandmarkets.com/research/g2qklv/european About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
French Automated Microbiology Market 2014: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics
M2 - Tue Feb 18, 6:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/wrb6dh/french_automated) has announced the addition of the "French Automated Microbiology Market 2014: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon. The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide. Review of Major Automated Systems - Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers. - The report profiles analyzers manufactured by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh. Infectious Diseases Analyzed in the Report AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia. For more information visit http://www.researchandmarkets.com/research/wr..._automated About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Tue Feb 18, 3:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/tc2bz6/hospital_acquired) has announced the addition of the "Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Nosocomial infections, most commonly called as hospital acquired diseases or healthcare associated infections (HAI),are acquired by patients during their stay in hospitals. Since the last decade, remarkable prevalence of nosocomial infections has been observed worldwide and its morbidity rate is rapidly growing. Patients with weak immune system, those exposed to improper hygiene conditions in hospitals, the high neonatal population in developing countries and elderly patients worldwide are highly susceptible to nosocomial infection. Aging of population is one of the major factors that has increased the incidence rate of hospital acquired diseases worldwide. Growing morbidity rate has resulted in a rise in nosocomial infection mortality globally. Contraction of nosocomial infection prolongs hospital stay of patients and ultimately the cost to the patients as well as the hospital increases. Though various diagnostic tests are available in the market for detection of infectious microorganisms, approximately 70% of such pathogens are becoming resistant to at least one of the anti-bacterial drugs most commonly used in nosocomial infection treatments, thus creating a challenge for healthcare professionals to treat such patients. Increasing resistance to commonly used antibiotics has created a demand for microorganism specific detection test for better assessment by healthcare professionals in order to provide appropriate treatment. Molecular diagnostics, PCR, microarrays and solid phase hybridization are some of the major techniques used for the diagnosis of nosocomial infections. The development of nucleic acid testing (NAT) diagnostic products and related platforms have enabled the entry of many players in the hospital acquired disease testing market. Nosocomial infections are mainly categorized into six types depending on the kind of infection, namely, hospital acquired pneumonia, urinary tract infection, blood stream infection, surgical site infection, MRSA (Methicillin-resistant Staphylococcus aureus)infection and other miscellaneous variants which include gastro intestinal infection, cardiovascular infections, respiratory infections and infections related to joints. Occurrence of hospital acquired UTI is highest in all types of nosocomial infections,leading to the highest market share by revenue of hospital acquired UTI testing segment in the overall HAI testing market. Geographically, North America dominates the global hospital acquired disease testing market and is followed by Europe. Government initiatives to control and prevent nosocomial infection in these regions and their rigorous implementation to reduce the disease morbidity rate is driving the growth of nosocomial infection testing market. Asia-Pacific is a lucrative market for HAI testing owing to increased incidence of hospital acquired disease testing in countries like China and India and the growing need to reduce healthcare expenditure by both, the healthcare institutions and patients equally. Contribution of Asian countries to the hospital acquired disease testing market is expected to increase further as the medical tourism industry flourishes in this region. Key Topics Covered - Introduction - Executive Summary - Market Overview - Global Hospital Acquired Disease Testing, by Infection Type - Global Hospital Acquired Disease Testing, by Geography - Recommendations - Company Profiles Companies Mentioned - Abbott Laboratories - Alere - bioMerieux - Becton, Dickinson and Company - Cantel Medical - Cepheid - Diatherix Laboratories - F. Hoffman-La Roche - Gen-Probe - Life Technologies - Meridian Bioscience - Nordion - Qiagen For more information visit http://www.researchandmarkets.com/research/tc...l_acquired About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Respiratory Diseases in the UK 2014: Market Outlook and Emerging Opportunities Available Now for Analysis
M2 - Mon Feb 17, 6:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/38644v/respiratory) has announced the addition of the "Respiratory Diseases in the UK 2014: Market Outlook and Emerging Opportunities" report to their offering. This new 281-page report presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for microbiology testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology - The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. - In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the author's proprietary data files was conducted. Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - BioRad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio - GenProbe - Hologic - ID Biomedical Innogenetics/Solvay - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - OrthoClinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac - Wako For more information visit http://www.researchandmarkets.com/research/38...espiratory About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
36.3% Return Seen to Date on SmarTrend Cepheid Call (CPHD)
Comtex SmarTrend(R) - Thu Feb 13, 4:43PM CST
SmarTrend identified an Uptrend for Cepheid (NASDAQ:CPHD) on September 5th, 2013 at $37.73. In approximately 5 months, Cepheid has returned 36.28% as of today's recent price of $51.41.
2014 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts
M2 - Thu Feb 13, 3:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/8tlq3p/2014_analysis_of) has announced the addition of the "2014 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts " report to their offering. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial/Private Labs - Blood Banks - Physician Offices - Public Health Labs For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Key Topics Covered: I. Introduction II. Hepatitis Worldwide Market and Technology Overview III. France: Market Size, Growth and Major Suppliers' Sales and Market Shares IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares V, Italy: Market Size, Growth and Major Suppliers' Sales and Market Shares VI. Spain: Market Size, Growth and Major Suppliers' Sales and Market Shares VII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares X. Alternative Market Penetration Strategies XI. Potential Market Entry Barriers and Risks XII. Competitive Assessments Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/8t...nalysis_of
2014 Analysis of the UK Hepatitis Diagnostics Market: Hospitals, Blood Banks, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
M2 - Mon Mar 10, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rjsvbf/2014_analysis_of) has announced the addition of the "2014 Analysis of the UK Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures" report to their offering. The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial/Private Labs - Blood Banks - Public Health Labs In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics/Grifols - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/rj...nalysis_of About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
43.9% Return Seen to Date on SmarTrend Cepheid Call (CPHD)
Comtex SmarTrend(R) - Fri Mar 07, 11:02AM CST
SmarTrend identified an Uptrend for Cepheid (NASDAQ:CPHD) on September 5th, 2013 at $37.73. In approximately 6 months, Cepheid has returned 43.95% as of today's recent price of $54.31.
Uptrend Call Working As Cepheid Stock Rises 45.6% (CPHD)
Comtex SmarTrend(R) - Fri Feb 28, 9:38AM CST
SmarTrend identified an Uptrend for Cepheid (NASDAQ:CPHD) on September 5th, 2013 at $37.73. In approximately 6 months, Cepheid has returned 45.61% as of today's recent price of $54.93.
Concise Analysis of the International Cancer Test Market
M2 - Thu Feb 27, 4:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/lbhbjn/cancer_test) has announced the addition of the "Concise Analysis of the International Cancer Test Market" report to their offering. Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year around the world than AIDS, Tuberculosis and Malaria combined. Cancer testing has tremendous growth opportunities for the next five years. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Accordingly, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The global cancer test market is expected to be more than US$ 14 Billion by 2018. This study provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters. Key Topics Covered: Table of Contents 1. Executive Summary 2. Global - Cancer Testing Market and New Cases 3. Global - Cancer Testing Market Share 4. Global - Segment Wise Cancer Testing Market 5. Global - Organ Specific Cancer Testing Market 6. Cancer Diagnostics- Companies Novel Test Platforms & Pipeline Analysis (20 Companies Analysis) Companies Mentioned: - Abbott - BD Diagnostics - Beckman Coulter - BioCurex - Cepheid - CytoCore - DiagnoCure - Gen-Probe - Genomic Health - Myriad Genetics - Panacea Pharmaceuticals - QIAGEN Marseille (Earlier Ipsogen) - Qiagen - Radient Pharmaceuticals - Roche - Siemens Heathcare Diagnostics - TrovageneInc. - Ventana Medical Systems - Vermillion - bioMerieux For more information visit http://www.researchandmarkets.com/research/lb...ancer_test
US Automated Microbiology Market 2014
M2 - Wed Feb 26, 9:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/p8czll/us_automated) has announced the addition of the "US Automated Microbiology Market 2014: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. United States Automated Microbiology Market 2014 is a new analysis of major business opportunities emerging in the US automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Specimen Types - Urine - Sterile Fluids: Blood, Serum, CSF - Throat Swabs, Respiratory Secretions - Genital Secretions - Stool - Abscess/Wound - Sputum - Saliva Applications - Microbial Identification - Antibiotic Susceptibility - Urine Screening - Blood Cultures Review of Major Automated Systems - Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers. The report profiles analyzers manufactured by: Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh. Technology Review - Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market. - Global listings of companies developing or marketing microbiology products by individual test. For more information visit http://www.researchandmarkets.com/research/p8..._automated About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Enteric Disease Testing Market 2014-2018: New Emerging Viruses and Bacteria Playing an Important Role in Diagnostics Industry
M2 - Wed Feb 26, 6:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/lrghlr/global_enteric) has announced the addition of the "Global Enteric Disease Testing Market 2014-2018" report to their offering. The analysts forecast the Global Enteric Disease Testing market to grow at a CAGR of 2.83 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of enteric diseases. The Global Enteric Disease Testing market has also been witnessing the emergence of new pathogens causing infections. However, the stringent regulatory approval could pose a challenge to the growth of this market. Key vendors dominating this space are Alere Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Cepheid Inc. and DiaSorin S.p.A. Other vendors mentioned in the report are Affymetrix Inc., Beckton, Dickenson and Co., Biomerica Inc., Coris BioConcept, Danaher Corp., Meridian Bioscience Inc., Quest Diagnostics Inc., R-Biopharm AG, and Trinity Biotech PLC. Commenting on the report, an analyst from the team said: Vendors are introducing new diagnostic tests for new found pathogens that are responsible for some other types of infectious diseases. These new pathogens include West Nile virus, respiratory syncytial virus, genital mycoplasma, C. difficile, norovirus, and rotavirus. C. difficile and rotavirus tests have seen the maximum level of acceptance in the market. Thus, the improvement in detection technology aiding in the identification of new pathogens is driving the need for enteric disease testing products. According to the report, one of the major drivers in the market is the increasing incidence of enteric diseases among the population, creating a need for testing methods that effectively diagnose diseases. For more information visit http://www.researchandmarkets.com/research/lr...al_enteric About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
A Whole New Opportunity For Hologic Inc?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Mon Feb 24, 5:30PM CST
Women's health specialist Hologic has had a rough go of it. At a time when most companies in the medical equipment or diagnostics markets can look back on a great two-year run in their share prices, Hologic's shares have chopped around and gone...
Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Mon Feb 24, 5:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/x9dvt9/molecular) has announced the addition of the "Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Molecular diagnostics primarily refers to a class of diagnostic test that analyzes nucleic acids or proteins at a molecular level. This class of diagnostics is identified as rapidly evolving and fastest growing segment of in-vitro diagnostics industry. Moreover, it is also considered as the most attractive and well established market for clinical applications. Traditionally, usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. But reduction in cost per sample analysis and labor cost, improvements in automation and introduction of advanced technologies has expanded the usage of molecular diagnostics in wide range of applications. The market for molecular diagnostics has expanded since 1990's with the introduction of PCR test for HIV and Chlamydia Trachomatis/Neisseria Gonorrhoeae (CT/NG). It is estimated that in the U.S. over 600 laboratories and 200 independent laboratories perform molecular diagnostics test to simplify and accelerate the testing process. Nowadays, molecular diagnostics tests are widely being adopted for testing infectious diseases (HIV, HCV, HPV HAI and others), genetic diseases, cancer testing and HLA testing. Similarly, molecular diagnostic kits are being used for blood donor screening and pharmacogenetics testing. Growth of this market in various segments is fuelled by the rise in incidence of chronic infections, growing geriatric population, increasing investments in R&D and increasing demand for personalized medicines. Currently, molecular diagnostics revenue is dominated by infectious diseases, capturing more 50% of the market share. Furthermore, growth of this segment will be triggered by rising incidences of hospital acquired infections (HAI) and thus HAI testing market is expected to witness a fastest growth rate in near future. This market is poised to grow at a CAGR of 15.1% from 2013-2019. HAI is being identified as a major cause of death and morbidity among hospitalized patients. It is estimated that each year approximately 14,000 Americans are diagnosed with C.difficile hospital acquired infection each year. Therefore, hospitals continue to adopt HAI testing as more virulent strains of these infections continue to surge. Similarly, rising cancer incidence is expected to drive the market for oncology testing and HPV testing during the analysis period. Next generation sequencing is growing rapidly and is estimated to emerge as the fastest growing segment. The technique is gaining importance owing to its rapid turnaround time, sensitivity and reduction in cost of sequencing. PCR market that accounted for a maximum share of the total molecular diagnostics market in 2012 is estimated to decline due to evolution of high throughput sequencing techniques. Key Topics Covered - Preface - Executive Summary - Market Overview - Molecular Diagnostics Market, by Technology - Global Molecular Diagnostics Market, by Applications - Global Molecular Diagnostics Market, by Geography - Global Molecular Diagnostics Market Share Analysis - Recommendations - Company Profiles Companies Mentioned - Abbott Laboratories - Becton Dickinson & Company - Bio-Rad - bioMerieux - Cepheid - Danaher Corporation (Beckman Coulter) - F. Hoffmann-La Roche - Hologic (Gen-Probe) - Myriad Genetics - Novartis International - Qiagen - Quest Diagnostics - Siemens - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/x9dvt9/molecular About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Updated Research Report on Cepheid - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 2:00PM CST
Recently, we issued an updated research report on Cepheid.
Respiratory Diseases in the US 2014: Market Outlook and Emerging Opportunities
M2 - Fri Feb 21, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/3tw5kb/respiratory) has announced the addition of the "Respiratory Diseases in the US 2014: Market Outlook and Emerging Opportunities" report to their offering. This new 283-page report presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for microbiology testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.. Methodology - The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. - In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the author's proprietary data files was conducted. Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - BioRad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio - GenProbe - Hologic - ID Biomedical Innogenetics/Solvay - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - OrthoClinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac - Wako For more information visit http://www.researchandmarkets.com/research/3t...espiratory About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Cepheid Shares Up 40.5% Since SmarTrend's Buy Recommendation (CPHD)
Comtex SmarTrend(R) - Fri Feb 21, 9:10AM CST
SmarTrend identified an Uptrend for Cepheid (NASDAQ:CPHD) on September 5th, 2013 at $37.73. In approximately 6 months, Cepheid has returned 40.49% as of today's recent price of $53.00.
Becton, Dickinson & Co Poised To Be A Large-Cap Growth Leader
Stephen D., Simpson,, The Motley Fool - Motley Fool - Wed Feb 19, 1:38PM CST
When the worst thing you can say about a company is that its stock doesn't look very cheap, that's not a bad situation. It is challenging for me to see substantial undervaluation in Becton Dickison these days, even given the company's excellent...
TDS and U.S. Cellular to release fourth quarter operating results and host conference call on Feb. 26, 2014
PR Newswire - Wed Feb 19, 9:44AM CST
Telephone and Data Systems, Inc. (NYSE: TDS) and United States Cellular Corporation (NYSE: USM) will be webcasting their fourth quarter operating results conference call on Feb. 26, 2014, at 10:30 a.m. EST (9:30 a.m. CST).
2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Blood Culture, Urine Screening and Immunodiagnostics
M2 - Tue Feb 18, 8:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/48jvmv/2014_automated) has announced the addition of the "2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. '2014 Automated Microbiology Market--A Global Strategic Outlook' is a new seven-country strategic analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies. Worldwide Market Overview - Estimated universe of laboratories performing microbiology testing by country. - Specimen, test volume and sales forecasts by country. Market Segmentation Analysis - Sales and market shares for major suppliers by individual test and country. - Volume and sales forecasts for over 100 infectious disease assays by individual test and country. - Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). - Review of the market dynamics, trends, structure, size, growth and major suppliers by country Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Exact Sciences - Fujirebio/Innogenetics - Hologic/Gen-Probe - Illumina - ID Biomedical/GSK - Kreatech - Li-Cor Biosciences - Life Technology - Lonza - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Novartis Diagnostics/Grifols - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Sierra Molecular - Shimadzu - Takara Bio - Tecan - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/48..._automated About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
European Automated Microbiology Market 2014: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Urine Screening, Immunodiagnostics
M2 - Tue Feb 18, 8:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/g2qklv/european) has announced the addition of the "European Automated Microbiology Market 2014: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. 'European Automated Microbiology Market 2014' is a new five-country strategic analysis of major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. This comprehensive five-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding European microbiology market, in evaluating emerging opportunities and developing effective business strategies. Geographic Coverage France, Germany, Italy, Spain and the UK Market Segmentation Analysis - Sales and market shares for major suppliers by individual test and country. - Volume and sales forecasts for over 100 infectious disease assays by individual test and country. - Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). - Review of the market dynamics, trends, structure, size, growth and major suppliers by country. Companies Mentioned: - Abbott - Alifax - Anagen - BD - Beckman Coulter/Danaher - Biochem - Biolog - bioMerieux - Bio-Rad - Biotrol - Cepheid - Curetis - GenMark - Hologic/Gen-Probe - HTG - Iris - J&J - Labsystems - Life Technologies - MiDI - Olympus - Qiagen - Roche - Siemens - Sy-Lab - Sysmex - Tecan - Thermo Fisher - Tosoh For more information visit http://www.researchandmarkets.com/research/g2qklv/european About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
French Automated Microbiology Market 2014: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics
M2 - Tue Feb 18, 6:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/wrb6dh/french_automated) has announced the addition of the "French Automated Microbiology Market 2014: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon. The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide. Review of Major Automated Systems - Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers. - The report profiles analyzers manufactured by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh. Infectious Diseases Analyzed in the Report AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia. For more information visit http://www.researchandmarkets.com/research/wr..._automated About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Tue Feb 18, 3:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/tc2bz6/hospital_acquired) has announced the addition of the "Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Nosocomial infections, most commonly called as hospital acquired diseases or healthcare associated infections (HAI),are acquired by patients during their stay in hospitals. Since the last decade, remarkable prevalence of nosocomial infections has been observed worldwide and its morbidity rate is rapidly growing. Patients with weak immune system, those exposed to improper hygiene conditions in hospitals, the high neonatal population in developing countries and elderly patients worldwide are highly susceptible to nosocomial infection. Aging of population is one of the major factors that has increased the incidence rate of hospital acquired diseases worldwide. Growing morbidity rate has resulted in a rise in nosocomial infection mortality globally. Contraction of nosocomial infection prolongs hospital stay of patients and ultimately the cost to the patients as well as the hospital increases. Though various diagnostic tests are available in the market for detection of infectious microorganisms, approximately 70% of such pathogens are becoming resistant to at least one of the anti-bacterial drugs most commonly used in nosocomial infection treatments, thus creating a challenge for healthcare professionals to treat such patients. Increasing resistance to commonly used antibiotics has created a demand for microorganism specific detection test for better assessment by healthcare professionals in order to provide appropriate treatment. Molecular diagnostics, PCR, microarrays and solid phase hybridization are some of the major techniques used for the diagnosis of nosocomial infections. The development of nucleic acid testing (NAT) diagnostic products and related platforms have enabled the entry of many players in the hospital acquired disease testing market. Nosocomial infections are mainly categorized into six types depending on the kind of infection, namely, hospital acquired pneumonia, urinary tract infection, blood stream infection, surgical site infection, MRSA (Methicillin-resistant Staphylococcus aureus)infection and other miscellaneous variants which include gastro intestinal infection, cardiovascular infections, respiratory infections and infections related to joints. Occurrence of hospital acquired UTI is highest in all types of nosocomial infections,leading to the highest market share by revenue of hospital acquired UTI testing segment in the overall HAI testing market. Geographically, North America dominates the global hospital acquired disease testing market and is followed by Europe. Government initiatives to control and prevent nosocomial infection in these regions and their rigorous implementation to reduce the disease morbidity rate is driving the growth of nosocomial infection testing market. Asia-Pacific is a lucrative market for HAI testing owing to increased incidence of hospital acquired disease testing in countries like China and India and the growing need to reduce healthcare expenditure by both, the healthcare institutions and patients equally. Contribution of Asian countries to the hospital acquired disease testing market is expected to increase further as the medical tourism industry flourishes in this region. Key Topics Covered - Introduction - Executive Summary - Market Overview - Global Hospital Acquired Disease Testing, by Infection Type - Global Hospital Acquired Disease Testing, by Geography - Recommendations - Company Profiles Companies Mentioned - Abbott Laboratories - Alere - bioMerieux - Becton, Dickinson and Company - Cantel Medical - Cepheid - Diatherix Laboratories - F. Hoffman-La Roche - Gen-Probe - Life Technologies - Meridian Bioscience - Nordion - Qiagen For more information visit http://www.researchandmarkets.com/research/tc...l_acquired About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Respiratory Diseases in the UK 2014: Market Outlook and Emerging Opportunities Available Now for Analysis
M2 - Mon Feb 17, 6:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/38644v/respiratory) has announced the addition of the "Respiratory Diseases in the UK 2014: Market Outlook and Emerging Opportunities" report to their offering. This new 281-page report presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for microbiology testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology - The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. - In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the author's proprietary data files was conducted. Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - BioRad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio - GenProbe - Hologic - ID Biomedical Innogenetics/Solvay - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - OrthoClinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac - Wako For more information visit http://www.researchandmarkets.com/research/38...espiratory About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
36.3% Return Seen to Date on SmarTrend Cepheid Call (CPHD)
Comtex SmarTrend(R) - Thu Feb 13, 4:43PM CST
SmarTrend identified an Uptrend for Cepheid (NASDAQ:CPHD) on September 5th, 2013 at $37.73. In approximately 5 months, Cepheid has returned 36.28% as of today's recent price of $51.41.
2014 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts
M2 - Thu Feb 13, 3:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/8tlq3p/2014_analysis_of) has announced the addition of the "2014 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts " report to their offering. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial/Private Labs - Blood Banks - Physician Offices - Public Health Labs For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Key Topics Covered: I. Introduction II. Hepatitis Worldwide Market and Technology Overview III. France: Market Size, Growth and Major Suppliers' Sales and Market Shares IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares V, Italy: Market Size, Growth and Major Suppliers' Sales and Market Shares VI. Spain: Market Size, Growth and Major Suppliers' Sales and Market Shares VII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares X. Alternative Market Penetration Strategies XI. Potential Market Entry Barriers and Risks XII. Competitive Assessments Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/8t...nalysis_of
(0)
(0)Cepheid Inc. (CPHD) Stock Research Links
Scroll down for more posts ▼